FindTrial
Sign In

Incidence, risk factors and mechanism of graft fibrosis after liver transplantation

Incidence, risk factors and mechanism of graft fibrosis after liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048265
Enrollment
Unknown
Registered
2021-07-05
Start date
2021-07-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver allograft fibrosis

Interventions

case series:none

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent liver biopsy in our hospital after liver transplantation; 2. Detailed clinical indicators.

Exclusion criteria

Exclusion criteria: Liver biopsy specimen failed.

Design outcomes

Primary

MeasureTime frame
liver allograft fibrosis score;—

Secondary

MeasureTime frame
liver function;follow-up time;operative parameters;—

Countries

China

Contacts

Public ContactSun Liying

Beijing Friendship Hospital, Capital Medical University

sunxlx@outlook.com+86 18612596060

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026